Reports for ALMOTRIPTAN

Ingredient

ALMOTRIPTAN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-ALMOTRIPTAN 6.25MG TABLET Resolved 2023-12-13 2024-03-25 213129
MYLAN-ALMOTRIPTAN 12.5MG TABLET Resolved 2023-10-30 2024-03-25 208613
TEVA-ALMOTRIPTAN 12.5MG TABLET Resolved 2023-01-12 2023-06-21 180894
MYLAN-ALMOTRIPTAN 12.5MG TABLET Resolved 2021-11-26 2022-03-23 149967
MYLAN-ALMOTRIPTAN 6.25MG TABLET Resolved 2021-11-26 2022-03-23 149970
ALMOTRIPTAN 12.5MG TABLET Resolved 2019-07-12 2019-09-07 89173
TEVA-ALMOTRIPTAN 12.5MG TABLET Resolved 2017-08-21 2019-08-29 19922
APO-ALMOTRIPTAN 6.25MG TABLET Resolved 2017-03-10 2019-05-14 27
APO-ALMOTRIPTAN 12.5MG TABLET Resolved 2017-03-10 2019-05-14 24
ALMOTRIPTAN 12.5MG TABLET Resolved 2019-01-28 2019-03-28 73682

Showing 1 to 10 of 15

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
AXERT 6.25MG 6.25MG TABLET Discontinued 2017-10-27 2017-10-28 27333
AXERT 12.5MG 12.5MG TABLET Discontinued 2017-10-27 2017-10-28 27357

Showing 1 to 4 of 4